Self-administered HPV Test Market
Self-administered HPV Test Market Study by DNA Based Assays and RNA Based Assays for Cervical Cancer and Vaginal Cancer for Healthcare Settings, Diagnostic Centers, and Others From 2024 to 2034
Analysis of Self-administered HPV Test Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT1150MR
- 31 Dec 2024
- Healthcare
- 170 Pages
- Tables
- Figures
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 6.1. By Test Type
- 6.2. By Indication
- 6.3. By End User
- 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Test Type
- 7.1. DNA-based HPV Test Kits
- 7.2. RNA-based HPV Test Kits
- 7.3. Hybrid Capture Technology-based Kits
- 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
- 8.1. Cervical Cancer
- 8.2. Vaginal Cancer
- 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
- 9.1. Hospitals and Clinics
- 9.2. Home Use
- 9.3. Diagnostic Centers
- 9.4. Reference Laboratories
- 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. East Asia
- 10.6. South Asia & Pacific
- 10.7. Middle East & Africa
- 11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 13. East Asia Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 14. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 15. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 16. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 17. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
- 18. Sales Forecast 2024 to 2034 by Test Type, By Indication, and By End User for 30 Countries
- 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 20. Company Profile
- 20.1. F. Hoffmann-La Roche Ltd
- 20.2. Qiagen N.V.
- 20.3. BD (Becton, Dickinson and Company)
- 20.4. Arbor Vita Corporation
- 20.5. Seegene Inc.
- 20.6. Thermo Fisher Scientific
- 20.7. Quest Diagnostics
- 20.8. STI Clinic
- 20.9. Check4Cancer
- 20.10. Rovers Medical Devices
- 20.11. Other Prominent Players